Success in the outdoor and fitness segments is breathing new life into Garmin; some concerns remain.
Waters' focus on operating discipline should serve it well in the constrained spending environment.
The Merck KGaA acquisition offer provides upside for Millipore shareholders.
Garmin is betting on the nüvifone to help it stay relevant as GPS functionality becomes pervasive on cell phones. With no history of success in phones, Garmin faces significant execution risk in a competitive industry.Adoption of GPS service by wireless carriers could cannibalize sales of Garmin's
Agilent's bioanalytical business should be a solid growth engine in the coming years.
Varian's VARI shareholders have approved the plan to sell the company to Agilent A at $52 per share. The transaction is scheduled to close by the end of the year.
Mettler-Toledo International MTD reported third-quarter results that were slightly better than our estimates, but this was not enough to shift our fair value estimate. As is the case with most firms in the medical instrument industry, the revenue deterioration Mettler experienced in the early part